Welcome to our dedicated page for BWX Technologies SEC filings (Ticker: BWXT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
BWX Technologies, Inc. filings document the regulatory record of a NYSE-listed nuclear manufacturing and engineering company serving government and commercial markets. Its disclosures cover operating and financial results, segment performance, backlog-related business activity, risk factors, and material events connected to nuclear propulsion, nuclear fuel, and commercial nuclear operations.
BWXT’s SEC filings also address governance and capital structure. Recent records include proxy materials and annual meeting voting results, board and executive officer matters, registered common stock information, material agreements, and convertible senior notes due 2030 with related subsidiary guarantees.
Kenneth J. Krieg, a director of BWX Technologies, Inc. (BWXT), reported a change in beneficial ownership on Form 4 related to dividend equivalent rights tied to deferred restricted stock units. The filing shows a transaction dated 09/05/2025 in which Dividend Equivalent Rights (DERs) were acquired at a reported price of $0. The explanation states these DERs accrued on nine restricted stock unit grants for which the reporting person elected to defer receipt of the underlying shares. Each RSU and DER represents a contingent right to receive one share of BWXT common stock, and the DERs will be delivered proportionately with the related RSUs. The table lists amounts including 32.04 (DERs) and a post-transaction beneficial ownership figure of 1,362.98.
BWX Technologies, Inc. (BWXT) Form 144 notice reports a proposed sale of 4,571 shares of common stock through Charles Schwab & Co., Inc. with an approximate sale date of 09/04/2025. The filer acquired these shares on 08/29/2025 by restricted stock lapse from BWX Technologies, Inc. and lists the nature of payment as equity compensation. The aggregate market value of the proposed sale is shown as $743,556.00 against 91,398,740 shares outstanding. The form states there were no securities sold by the filer in the past three months and includes the required representation that the filer is unaware of undisclosed material adverse information.
Leland D. Melvin, identified as a director of BWX Technologies, Inc. (BWXT), reported a sale of 600 common shares on 08/11/2025 at a price of $178.265, leaving beneficial ownership of 5,579 shares. The Form 4 was executed by attorney-in-fact Theresa B. Taylor and signed on 08/12/2025. No derivative transactions were reported.
BWX Technologies insider Ronald O. Whitford Jr., SVP, General Counsel and Secretary, exercised employee stock options to acquire 2,092 shares at a $61.70 exercise price and immediately sold those 2,092 shares at a weighted average price of $177.4342 on 08/11/2025. The Form 4 shows his beneficial common stock position following these transactions was 10,149 shares (one line shows 12,241 after the acquisition and another shows 10,149 after the sale). The filing also reports he continues to hold employee stock options covering 4,184 underlying shares, with an expiration date of 02/27/2033 and a vesting schedule of three equal annual installments beginning 02/27/2024.
BWX Technologies reported a proposed sale of 2,092 common shares by a person who acquired the shares through an employee stock option exercise. The shares were handled by Charles Schwab & Co., Inc. with an aggregate market value of $371,192 and the issuer's outstanding shares listed as 91,398,740. The transaction is described as a broker payment for a cashless exercise, and the notice states the seller represents they are not aware of any undisclosed material adverse information about the company.
The sale is reported under Rule 144 and the filer indicates no other sales in the past three months. The transaction and sale date are shown as 08/11/2025, and the shares were listed for sale on the NYSE.
Gonzalo R. Cajade, SVP and Chief Human Resources Officer of BWX Technologies (BWXT), reported initial beneficial ownership on Form 3. He directly owns 170 shares of common stock and holds equity awards including 996 restricted stock units (RSUs) and stock options covering 3,369 shares.
The RSUs and options vest in three equal annual installments beginning July 1, 2026. The reported stock options carry a $140.37 exercise price and expire on July 1, 2035. All holdings are reported as direct ownership.
BWX Technologies (BWXT) submitted a Form 144 reporting a proposed sale of 600 common shares through Wells Fargo Clearing Services on the NYSE with an aggregate market value of $105,668.49. The filing lists 91,398,740 shares outstanding and gives an approximate sale date of 08/11/2025.
The securities were acquired as compensation from the issuer on 08/08/2019. The form states there were no securities sold in the past three months by the reporting person and includes the standard representation that the filer is not aware of undisclosed material adverse information.
Meguid Omar Fathi is listed as the reporting person and identified as SVP and Chief Digital Officer of BWX Technologies, Inc. (BWXT). The Form 4 discloses a sale on 08/06/2025 of 2,261 shares of common stock at $179.8401 per share. Following the reported transaction the filing shows 2,361 shares beneficially owned, held directly. The Form 4 was signed via attorney-in-fact on 08/08/2025.
BWX Technologies, Inc.'s President and CEO Rex D. Geveden reported selling a total of 25,000 shares of common stock on August 6, 2025 in sales categorized as open market or private transactions. The reported per-share prices are weighted averages of $178.989 and $179.6898, with underlying trades executed between $178.5450 and $179.5400 per share, and between $179.5500 and $179.7500 per share, according to notes. After these transactions, Geveden directly owned 197,594 shares of BWX Technologies common stock.